Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Janneke van der Woude

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Expert Opinion on Biological Therapy|August 21, 2007
Biologics in Crohn's disease: searching indicators for outcomeC Janneke van der Woude, Daniel W Hommes
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Are we ready for top-down therapy for inflammatory bowel diseases: proC Janneke van der Woude, Daniel W Hommes
Clinical and Experimental Gastroenterology|June 23, 2011
The impact of biologics on health-related quality of life in patients with inflammatory bowel diseaseLauran Vogelaar, Adriaan Van't Spijker, C Janneke van der Woude
Gut|January 17, 2014
Management of gastrointestinal and liver diseases during pregnancyC Janneke van der Woude, Herold J Metselaar, Silvio Danese
Trends in Molecular Medicine|July 13, 2013
Do pregnancy-related changes in the microbiome stimulate innate immunity?Sergey R Konstantinov, C Janneke van der Woude, Maikel P Peppelenbosch
Nature Reviews. Gastroenterology & Hepatology|December 12, 2018
Fatigue in IBD: epidemiology, pathophysiology and managementNienke Z Borren, C Janneke van der Woude, Ashwin N Ananthakrishnan
Expert Review of Gastroenterology & Hepatology|July 5, 2018
Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune systemJantien W Wieringa, Gertjan J Driessen, C Janneke Van Der Woude
International Journal of Colorectal Disease|June 28, 2020
Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse eventsMitchell R K L Lie, Emma Paulides, C Janneke van der Woude
Inflammatory Bowel Diseases|December 22, 2016
Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's DiseaseMitchell R K L Lie, Joany E Kreijne, C Janneke van der Woude
Frontline Gastroenterology|September 1, 2022
Inflammatory bowel disease negatively impacts household and family lifeEmma Paulides, Demi Cornelissen, Annemarie C de Vries, et al.
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Expert Opinion on Biological Therapy|August 21, 2007
Biologics in Crohn's disease: searching indicators for outcomeC Janneke van der Woude, Daniel W Hommes
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Are we ready for top-down therapy for inflammatory bowel diseases: proC Janneke van der Woude, Daniel W Hommes
Clinical and Experimental Gastroenterology|June 23, 2011
The impact of biologics on health-related quality of life in patients with inflammatory bowel diseaseLauran Vogelaar, Adriaan Van't Spijker, C Janneke van der Woude
Gut|January 17, 2014
Management of gastrointestinal and liver diseases during pregnancyC Janneke van der Woude, Herold J Metselaar, Silvio Danese
Trends in Molecular Medicine|July 13, 2013
Do pregnancy-related changes in the microbiome stimulate innate immunity?Sergey R Konstantinov, C Janneke van der Woude, Maikel P Peppelenbosch
Nature Reviews. Gastroenterology & Hepatology|December 12, 2018
Fatigue in IBD: epidemiology, pathophysiology and managementNienke Z Borren, C Janneke van der Woude, Ashwin N Ananthakrishnan
Expert Review of Gastroenterology & Hepatology|July 5, 2018
Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune systemJantien W Wieringa, Gertjan J Driessen, C Janneke Van Der Woude
International Journal of Colorectal Disease|June 28, 2020
Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse eventsMitchell R K L Lie, Emma Paulides, C Janneke van der Woude
Inflammatory Bowel Diseases|December 22, 2016
Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's DiseaseMitchell R K L Lie, Joany E Kreijne, C Janneke van der Woude
Frontline Gastroenterology|September 1, 2022
Inflammatory bowel disease negatively impacts household and family lifeEmma Paulides, Demi Cornelissen, Annemarie C de Vries, et al.
Pageof 20